Our Company
R&D
Product Pipeline
Clinical Trials
Investors
Carreers
Corporate Governance
Stock Information
News
Press Releases
SEC Filings
Analysts
Corporate Presentations
Annual Reports
Calendar of Events
Request Investor Pack
Home
Investors
News
Press Releases
2000
Press Releases
If you would like to be alerted when a press release is added to this site, please register with the
Alerting Service
.
2008
|
2007
|
2006
|
2005
|
2004
|
2003
|
2002
|
2001
|
2000
|
1999
|
1998
Select a month
All
January
February
March
April
May
June
July
August
September
October
November
December
Select a year
All
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
Search for:
12/05/2000
Cyclacel Announces Collaboration with CV Therapeutics, Inc
11/03/2000
Cyclacel Appoints Dr. Athos Gianella-Borradori as Director, Medical Affairs
09/13/2000
Cyclacel Acquires the Assets of Fluorescience Limited
09/08/2000
Cyclacel Appoints Prof. Robert Westwood as Head of Preclinical Development
08/11/2000
Cyclacel Announces Patent Application for Improved Penetratin®
03/08/2000
Cyclacel Announces Major Cancer Genomics Initiative
02/24/2000
Cyclacel Announces Publication of Penetratin® Drug Conjugate Patent Application
01/18/2000
Cyclacel Appoints Dr Robert Jackson to Scientific Advisory Board
01/07/2000
Knighthood for Cyclacel's Top Scientist and Founder
Go to top
Print page